Parham Mirshahpanah

Summary

Publications

  1. ncbi request reprint Relationship of patch test positivity in a general versus an eczema population
    Parham Mirshahpanah
    RBA Dermatology Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA, USA
    Contact Dermatitis 56:125-30. 2007
  2. ncbi request reprint Models in acnegenesis
    Parham Mirshahpanah
    TRG Inflammation Immunology, Bayer Schering Pharma AG, Mullerstrasse 178, 13342 Berlin, Germany
    Cutan Ocul Toxicol 26:195-202. 2007
  3. ncbi request reprint Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate
    Parham Mirshahpanah
    TRG Inflammation Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Cutan Ocul Toxicol 26:375-82. 2007
  4. doi request reprint Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors
    Julie L Lucas
    Bayer HealthCare Pharmaceuticals, Richmond, CA 94701, USA
    Cell Immunol 257:97-104. 2009
  5. ncbi request reprint CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity
    Parham Mirshahpanah
    TRG Inflammation and Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Exp Dermatol 17:30-4. 2008
  6. ncbi request reprint Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate
    Parham Mirshahpanah
    Research Business Area Dermatology, Berlex Biosciences, Richmond, CA, USA
    Exp Dermatol 16:753-61. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Relationship of patch test positivity in a general versus an eczema population
    Parham Mirshahpanah
    RBA Dermatology Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA, USA
    Contact Dermatitis 56:125-30. 2007
    ..Taken together, data obtained in eczema patients may be viewed as part of a complex biology and may eventually be of use in aiding validation of predictive dermatotoxilogic assays and in public health assessments...
  2. ncbi request reprint Models in acnegenesis
    Parham Mirshahpanah
    TRG Inflammation Immunology, Bayer Schering Pharma AG, Mullerstrasse 178, 13342 Berlin, Germany
    Cutan Ocul Toxicol 26:195-202. 2007
    ..Developing an animal model that is true to the human condition will require further epidemiological evaluation of acne to elucidate the complex condition...
  3. ncbi request reprint Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate
    Parham Mirshahpanah
    TRG Inflammation Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Cutan Ocul Toxicol 26:375-82. 2007
    ....
  4. doi request reprint Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors
    Julie L Lucas
    Bayer HealthCare Pharmaceuticals, Richmond, CA 94701, USA
    Cell Immunol 257:97-104. 2009
    ....
  5. ncbi request reprint CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity
    Parham Mirshahpanah
    TRG Inflammation and Immunology, Bayer Schering Pharma AG, Berlin, Germany
    Exp Dermatol 17:30-4. 2008
    ..We conclude that blocking CCR4 and CCR10 simultaneously, or their ligands, should be beneficial in the treatment of T-cell-mediated skin diseases...
  6. ncbi request reprint Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate
    Parham Mirshahpanah
    Research Business Area Dermatology, Berlex Biosciences, Richmond, CA, USA
    Exp Dermatol 16:753-61. 2007
    ..The degree to which this observation may translate into a clinical setting requires confirmation...